Metraipolis › archive › dc_ea03c710b89a

Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy — Europe PMC PMID:41714421

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41714421
DOI
10.1007/s00467-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-05T14:24:07.611Z
SHA-256 of the archived text
8300be16b56cae1842485c2be973ade145eebfe5cfa67e583c1ee1011bd85f97
Stable URL of this page
https://metraipolis.com/documento/dc_ea03c710b89a

How to cite

Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy — Europe PMC PMID:41714421 — Europe PMC (en), https://europepmc.org/article/MED/41714421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea03c710b89a (Metraipolis archive dc_ea03c710b89a, sha256 8300be16b56cae1842485c2be973ade145eebfe5cfa67e583c1ee1011bd85f97)
BibTeX
@misc{dcea03c710b89a,
  title = {Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy — Europe PMC PMID:41714421},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41714421},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea03c710b89a; sha256 8300be16b56cae1842485c2be973ade145eebfe5cfa67e583c1ee1011bd85f97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41714421. Agents can read the archived copy with the MCP tool read_document.